EGCG

You have access
Epigallocatechin Gallate Inhibits Cell Growth and Hedgehog Signalling in Human Rhabdomyosarcoma Cell Lines
BENJAMIN F.B. MAYER, MATIAS J. STAGNO, JÖRG FUCHS, STEVEN W. WARMANN and EVI SCHMID

Anticancer Research March 2023, 43 (3) 1025-1030; DOI: https://doi.org/10.21873/anticanres.16247
You have access
Epigallocatechin-3-gallate Enhances Radiation Sensitivity in Colorectal Cancer Cells Through Nrf2 Activation and Autophagy
TUMENJIN ENKHBAT, MASAAKI NISHI, KOZO YOSHIKAWA, HIGASHIJIMA JUN, TAKUYA TOKUNAGA, CHIE TAKASU, HIDEYA KASHIHARA, DAICHI ISHIKAWA, MASAHIDE TOMINAGA and MITSUO SHIMADA

Anticancer Research November 2018, 38 (11) 6247-6252; DOI: https://doi.org/10.21873/anticanres.12980
You have access
(–)-Epigallocatechin-3-gallate Down-regulates Doxorubicin-induced Overexpression of P-glycoprotein Through the Coordinate Inhibition of PI3K/Akt and MEK/ERK Signaling Pathways
HANA SATONAKA, KUMIKI ISHIDA, MIHO TAKAI, RYOJI KOIDE, RYOTA SHIGEMASA, JUN UEYAMA, TETSUYA ISHIKAWA, KAZUHIKO HAYASHI, HIDEMI GOTO and SHINYA WAKUSAWA

Anticancer Research November 2017, 37 (11) 6071-6077;
You have access
Curcumin and Epigallocatechin Gallate Inhibit the Cancer Stem Cell Phenotype via Down-regulation of STAT3–NFκB Signaling
SEYUNG S. CHUNG and JAYDUTT V. VADGAMA

Anticancer Research January 2015, 35 (1) 39-46;
You have access
Green Tea Polyphenol Epigallocatechin 3-Gallate, Contributes to the Degradation of DNMT3A and HDAC3 in HCT 116 Human Colon Cancer Cells
VONDINA R. MOSELEY, JAY MORRIS, REBECCA W. KNACKSTEDT and MICHAEL J. WARGOVICH

Anticancer Research December 2013, 33 (12) 5325-5333;

Main menu

User menu

Search

EGCG